(19)
(11) EP 3 153 023 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.06.2022 Bulletin 2022/23

(45) Mention of the grant of the patent:
16.03.2022 Bulletin 2022/11

(21) Application number: 16171888.7

(22) Date of filing: 02.11.2009
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/275; A61K 45/06; C07D 413/04; C07D 413/14; C07F 5/025; A61P 35/00; C07D 487/04; A61K 31/337; A61K 31/455; A61K 31/519; A61K 31/5377; A61K 31/7068
 
C-Sets:
A61K 31/275, A61K 2300/00;

(54)

BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE

BENZOXAZOLKINASEHEMMER UND VERFAHREN ZUR VERWENDUNG

INHIBITEURS DE KINASE DE BENZOXAZOLE ET LEURS PROCÉDÉS D'UTILISATION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 03.11.2008 US 198200 P
16.12.2008 US 201923 P
20.04.2009 US 214261 P
31.07.2009 US 230655 P
17.09.2009 US 586241
17.09.2009 US 586309

(43) Date of publication of application:
12.04.2017 Bulletin 2017/15

(62) Application number of the earlier application in accordance with Art. 76 EPC:
09823947.8 / 2365750

(73) Proprietor: Calithera Biosciences, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • Ren, Pingda
    San Diego, CA 92130 (US)
  • Liu, Yi
    San Diego, CA 92130 (US)
  • Li, Liansheng
    San Diego, CA 92130 (US)
  • Chan, Katrina
    San Diego, CA 92122 (US)
  • Wilson, Troy, Edward
    San Marino, CA 91108 (US)

(74) Representative: Harris, Jennifer Lucy 
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)


(56) References cited: : 
WO-A1-2010/036380
WO-A2-2010/129816
US-A1- 2007 293 516
 WO-A2-2007/079164
US-A1- 2007 112 005
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).